Switchboard: +358 29 522 3341
fax +358 29 522 3002
Calls received by Fimea's telephone exchange may be recorded in order to improve our customer service. Only your discussion with the exchange operator will be recorded. The recordings will not be used for any other purposes.
Please note that Fimea safeguards and develops the medical field on a national level. We can not comment on the medication and medical care of an individual patient. In such case, please contact your medical care provider. You can as well ask for advice in pharmacies.
Registrar's office:
[email protected]
tel. +358 29 522 3602
fax +358 29 522 3002
(See more detailed instructions for using the secure mail service by clicking on the question mark symbol in the secure mail service.)
Registrar's office is open 9–15.
Documents can be submitted to Helsinkis and Kuopios offices 8–16.15.
Read more: Fimea registrar’s office service hours changing on 1 March 2023
Adress
Postal address:
P.O. Box 55, FI-00034 FIMEA, FINLAND
Visiting addresses:
Hallituskatu 12-14, 70100 Kuopio
Mannerheimintie 166, 00300 Helsinki
Mannerheimintie 166, 00300 Helsinki (Laboratory)
Itsenäisyydenaukio 2, 20800 Turku
Yliopistonkatu 38, 33100 Tammerfors
Aapistie 1 (Kastelli Research Center), 90220 Oulu
Delivery address for courier service:
Mannerheimintie 166, 00300 Helsinki, Finland
8–16.15
Staff contact information
E-mail addresses follow the form [email protected]
It is forbidden to use address information for direct marketing without the consent of the person concerned.
***
If you suspect that you have experienced an adverse drug reaction, tell your attending physician or dentist about it.
Read more about adverse reactions.
Urgent matters relating to pharmaceutical service for healthcare professionals
Product defects (24hrs):
[email protected]
tel. +358 29 522 3202
Special permissions:
Marketing authorisation applications
Applications for marketing authorisations must be submitted using the common EU application form regardless of the procedure applied.
Instructions for electronic marketing authorisation submissions.
Clinical Trials
Clinical trials' customer service tel. +358 29 522 3402 (open 9-15)
Communications
(If you have questions about your medication or vaccinations, please contact your doctor or vaccinating entity.)
Communications Director Minna Takaloeskola
tel. +358 29 522 3115
Communications Manager Katja Lindgren-Äimänen
tel. +358 29 522 3118
Web Specialist Tuukka Tenhunen
tel. +358 29 522 3117
Communications Specialist Riitta Vuorela
tel. +358 29 522 3119
Communications Specialist Petra Nylund
tel +358 29 522 3121
Communications Assistant Anna Tamminen
tel +358 29 522 3147
Pharmaceutical Bulletin Sic! Drug Information from Fimea
Editors: [email protected]
Senior Specialist Tiina Kuosa
tel. +358 29 522 3269
Management:
Director General Eija Pelkonen
tel. +358 29 522 3100
Supervision and availability
Director Susanna Peltoniemi
tel. +358 29 522 3210
Head of Unit Eeva Leinonen, Inspectorate
tel + 358 29 522 3220
Head of Unit Timo Mauriala, Product Quality Control Unit
tel. +358 29 522 3214
a.i. Head of Unit Jari Knuuttila, Medical Devices Unit
tel. +358 29 522 3274
Marketing authorisations
Director Anna Siira
tel- + 358 29 522 3300
Head of Unit Marjo-Riitta Helle, Pharmaco-Biological Unit
tel. +358 29 522 3320
Head of Unit Leena Pietilä, Regulatory Processes Unit
tel. +358 29 522 3360
Head of Unit Jukka Sallinen, Clinico-Pharmacological Unit
tel. +358 29 522 3410 (on leave of absence, deputy: Head of Section Kari Punnonen, Clinico-Pharmacological Section, tel. +358 29 522 3440)
Head of Unit Irmeli Happonen, Veterinary Medicines Unit
tel. +358 29 522 3330
Safety and effectiveness
Director Piia Vuorela
tel.+358 29 522 3510
Joint services
Director Sari Kujala
tel. + 358 29 522 3610
Finance Director Lauri Kaanela
tel. +358 29 522 3630
HR chef Johanna Ollila
tel. +358 29 522 3653
Legal Services
Head of Unit Marjo Mustonen
tel. +358 29 522 3657
Document Management
Senior Planning Officer Jaana Pohjonen
tel. +358 29 522 3636
Development and Information Services
Development Manager Teemu Laakso
tel. +358 29 522 3629
ICT-Manager Mirke Turunen
tel. +358 29 522 3640
Chief Researcher Leena Saastamoinen
tel. +358 29 522 3659